Biomarkers

Biomarkers still become progressively relevant in analysis and care applications, as proven by the worldwide marketplace for the product concerned in their identification, validation, and use calculable at $8.3 billion in 2007 and projected to extend to $15 billion in 2010. The fast pace of activity during this space is any underlined by a careless review of the publication house, wherever the quantity of relevant scientific articles generated annually has doubled from 20,000 to 40,000 over the past decade. AACR, in partnership with the Food and Drug Administration (FDA) and National Cancer Institute (NCI), shaped the AACR-FDA-NCI Cancer Biomarkers cooperative (CBC) to accelerate the interpretation of cancer medicine into the clinic by shaping the processes for the effective development of valid biomarkers and their use in clinical trials for optimum patient profit.

    Related Conference of Biomarkers

    August 22-23, 2019

    5th International Congress on Epigenetics & Chromatin

    Vienna, Austria
    August 30-31, 2019

    International Conference on Genetic Disorders

    Bangkok, Thailand
    September 13-14, 2019

    12th World Congress on Cell & Tissue Science

    Singapore
    October 21-22, 2019

    23rd European Biotechnology Congress

    Zurich, Switzerland
    November 26-27, 2019

    International Conference On Genomics and Molecular Biology

    Lisbon | Portugal
    November 26-27, 2019

    International Conference on Cell and Gene Therapy

    | Lisbon, Portugal
    February 24-25, 2020

    24th Global Congress on Biotechnology

    London, UK
    March 16-17, 2020 |

    12th World Congress and Expo on Cell & Stem Cell Research

    Chicago, Illinois, USA
    May 21-22, 2020

    24th European Biotechnology Congress

    London,UK

    Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in